| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.03 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |